⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002123907

Kalinichev Mikhail

Reports to the SEC for 1 company · GENEVA

Transactions

4

Companies

1

Filings

1

CIK

0002123907

Forms 4 and 5

Insider transactions

4 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-02	ADXNAddex Therapeutics Ltd.D Disposition to Issuer	HEAD OF TRANSLATIONAL SCIENCE	DDisposition to Issuer	−307K sh	—	—	0
2026-09-02	ADXNAddex Therapeutics Ltd.A Award	HEAD OF TRANSLATIONAL SCIENCE	AAward	+307K sh	—	—	306,765
2026-09-02	ADXNAddex Therapeutics Ltd. · Stock-option (Right to Buy)D Disposition to Issuer	HEAD OF TRANSLATIONAL SCIENCE	DDisposition to Issuer	−200K sh	—	—	0
2026-09-02	ADXNAddex Therapeutics Ltd. · Stock-option (Right to Buy)A Award	HEAD OF TRANSLATIONAL SCIENCE	AAward	+200K sh	—	—	200,000

Recent filings

1

Accepted (ET)
Sep 44
Kalinichev Mikhail0001104659-26-105506
SEC(opens sec.gov)

Companies

1

Addex Therapeutics Ltd.HEAD OF TRANSLATIONAL SCIENCEADXN

Address

CHEMIN DES MINES 9

GENEVA, CH-1202